Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AU Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (31)
Cancellation by sponsor (4)
Prescription medicine registration (4)

Date

2026 (11)
2025 (2)
2024 (4)
2023 (10)
2022 (3)
2021 (8)
2018 (1)

Search

Sponsor content

39 result(s) found, displaying 21 to 30

B-PATCH buprenorphine 40 microgram/hour transdermal drug delivery system sachet (398558)

2 November 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for B-PATCH buprenorphine 40 microgram/hour transdermal drug delivery system sachet.
B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet (398557)

2 November 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet.
Ting (402573)

19 January 2023

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Ting.
OXONAL (AU Pharma Pty Ltd)

2 April 2024

Prescription medicine registration

Active ingredients: naloxone hydrochloride dihydrate, oxycodone hydrochloride.
SuperBeauty (395991)

15 September 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SuperBeauty.
OXONAL 5/2.5 oxycodone hydrochloride 5 mg /naloxone hydrochloride 2.5 mg modified release tablet blister pack (355284)

18 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for OXONAL 5/2.5 oxycodone hydrochloride 5 mg /naloxone hydrochloride 2.5 mg modified release tablet blister pack.
B-PATCH (AU Pharma Pty Ltd)

24 October 2023

Prescription medicine registration

Active ingredients: Buprenorphine.
Pandemic Influenza Vaccine H5N1 BAXTER (whole virion, vero cell derived, inactivated) suspension for injection 0.5 ml dose syringe Cancelled under Section 30(1)(c) of the Act

13 October 2023

Cancellation by sponsor

Requested by AU Pharma Pty Ltd
Pandemic Influenza Vaccine H5N1 BAXTER (whole virion, vero cell derived, inactivated) suspension for injection 0.5 ml dose vial Cancelled under Section 30(1)(c) of the Act

13 October 2023

Cancellation by sponsor

Requested by AU Pharma Pty Ltd
B-PATCH buprenorphine 15 microgram/hour transdermal drug delivery system sachet (350990)

11 November 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for B-PATCH buprenorphine 15 microgram/hour transdermal drug delivery system sachet.

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.